AUGUSTA NOBEL: Open Payments
NPI 1851955611 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$547 in 17 payments from 8 companies in 2025. Trend: 2023 $106 · 2024 $33 · 2025 $547
Food & beverage: $547
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 2 | $162 |
| Otsuka America Pharmaceutical, Inc. | 3 | $140 |
| ABBVIE INC. | 3 | $61 |
| Braeburn Inc. | 3 | $56 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $45 |
| Gilead Sciences, Inc. | 2 | $44 |
| Neurocrine BioSciences, Inc. | 1 | $23 |
| Indivior Inc. | 1 | $16 |
Products named: SPRAVATO, ABILIFY MAINTENA, MAVYRET, BRIXADI, CAPLYTA, INGREZZA, REXULTI, SUBLOCADE.
Industry payments across IN — which companies pay providers there.
